Rep. Julie Johnson Sells UnitedHealth Group Incorporated (NYSE:UNH) Stock

Key Points

• Representative Julie Johnson sold shares of UnitedHealth Group Incorporated (NYSE:UNH) between $1,001 and $15,000 on July 24th, 2025, as disclosed in a filing on August 14th.
• UnitedHealth Group recently reported a quarterly earnings miss, with earnings per share of $4.08 compared to the consensus estimate of $4.45, despite revenue growth of 12.9% year-over-year.
• The company declared a quarterly dividend of $2.21 per share, to be paid on September 23rd, representing an annualized yield of 2.9%.

Representative Julie Johnson (D-Texas) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on July 24th. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Seagate Technology NASDAQ: STX on 7/29/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 7/29/2025.
• Sold $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 7/25/2025.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 7/25/2025.
• Purchased $1,001 - $15,000 in shares of Chevron NYSE: CVX on 7/25/2025.
• Sold $1,001 - $15,000 in shares of Exxon Mobil NYSE: XOM on 7/25/2025.
• Sold $1,001 - $15,000 in shares of Philip Morris International NYSE: PM on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of CME Group NASDAQ: CME on 7/22/2025.
• Sold $1,001 - $15,000 in shares of BlackRock NYSE: BLK on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 7/22/2025.

UnitedHealth Group Stock Performance

Shares of UNH traded up $32.53 during midday trading on Friday, reaching $304.02. The stock had a trading volume of 67,934,484 shares, compared to its average volume of 21,947,932. The firm has a market cap of $275.34 billion, a PE ratio of 13.17, a P/E/G ratio of 1.96 and a beta of 0.43. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a 50 day simple moving average of $288.91 and a 200-day simple moving average of $395.81. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the firm earned $6.80 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently made changes to their positions in the company. LFA Lugano Financial Advisors SA bought a new position in UnitedHealth Group during the second quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the fourth quarter worth about $26,000. Bayforest Capital Ltd boosted its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the period. Sagard Holdings Management Inc. bought a new position in UnitedHealth Group during the second quarter worth about $29,000. Finally, Islay Capital Management LLC bought a new position in UnitedHealth Group during the second quarter worth about $31,000. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. Hsbc Global Res cut shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. KeyCorp decreased their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Finally, Barclays reaffirmed an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Hold" and a consensus target price of $366.52.

Insiders Place Their Bets

In other news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.28% of the stock is owned by corporate insiders.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.